×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
5969 views

Moderators : Anna Fagotti & Gwenaël Ferron

Agenda

  Introduction
Anna Fagotti & Gwenaël Ferron
 
  HIPEC in first setting
Willemien Van Driel
 
  HIPEC in recurrent disease
Jean-Marc Classe
 
  Oncologic issues
Laurence Gladieff
 
  Take home message
Anna Fagotti
 

 

Shooting date : 2024-02-06
Last update : 2024-04-03
2 comments
Join the Discussion
  • ANIK G. Can't wait to see this webinar. Wonderful and much anticipated topic.

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Gwenaël F. Dear Anik. The VOD is available !!

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Tuesday, March 22nd 2022 from 07pm to 08:50pm (GMT+1)
      Honolulu : Tuesday, March 22nd 2022 from 08am to 09:50am (GMT+1)
      San Francisco : Tuesday, March 22nd 2022 from 10am to 11:50am (GMT+1)
      New York : Tuesday, March 22nd 2022 from 01pm to 02:50pm (GMT+1)
      Buenos Aires : Tuesday, March 22nd 2022 from 03pm to 04:50pm (GMT+1)
      London / Dublin : Tuesday, March 22nd 2022 from 06pm to 07:50pm (GMT+1)
      Paris / Berlin : Tuesday, March 22nd 2022 from 07pm to 08:50pm (GMT+1)
      Istanbul : Tuesday, March 22nd 2022 from 08pm to 09:50pm (GMT+1)
      Moscou / Dubaï : Tuesday, March 22nd 2022 from 10pm to 11:50pm (GMT+1)
      Bangkok : Wednesday, March 23rd 2022 from 01am to 02:50am (GMT+1)
      Shanghai : Wednesday, March 23rd 2022 from 02am to 03:50am (GMT+1)
      Tokyo : Wednesday, March 23rd 2022 from 03am to 04:50am (GMT+1)
      Sydney : Wednesday, March 23rd 2022 from 04am to 05:50am (GMT+1)
      Wellington : Wednesday, March 23rd 2022 from 06am to 07:50am (GMT+1)

      Cancer de l’ovaire

      Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie

      Share
      Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
      Honolulu : Wednesday, November 16th 2022 from 07am to 08:30am (GMT+1)
      San Francisco : Wednesday, November 16th 2022 from 09am to 10:30am (GMT+1)
      New York : Wednesday, November 16th 2022 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Wednesday, November 16th 2022 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Wednesday, November 16th 2022 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
      Istanbul : Wednesday, November 16th 2022 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Wednesday, November 16th 2022 from 09pm to 10:30pm (GMT+1)
      Bangkok : Thursday, November 17th 2022 from 12am to 01:30am (GMT+1)
      Shanghai : Thursday, November 17th 2022 from 01am to 02:30am (GMT+1)
      Tokyo : Thursday, November 17th 2022 from 02am to 03:30am (GMT+1)
      Sydney : Thursday, November 17th 2022 from 03am to 04:30am (GMT+1)
      Wellington : Thursday, November 17th 2022 from 05am to 06:30am (GMT+1)

      Cancer de l’ovaire et iPARP

      Share
      Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
      Honolulu : Monday, November 28th 2022 from 07am to 08:30am (GMT+1)
      San Francisco : Monday, November 28th 2022 from 09am to 10:30am (GMT+1)
      New York : Monday, November 28th 2022 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Monday, November 28th 2022 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
      Istanbul : Monday, November 28th 2022 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Monday, November 28th 2022 from 09pm to 10:30pm (GMT+1)
      Bangkok : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
      Shanghai : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
      Tokyo : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
      Sydney : Tuesday, November 29th 2022 from 03am to 04:30am (GMT+1)
      Wellington : Tuesday, November 29th 2022 from 05am to 06:30am (GMT+1)

      Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

      Share
      Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
      Honolulu : Tuesday, November 21st 2023 from 07am to 08:30am (GMT+1)
      San Francisco : Tuesday, November 21st 2023 from 09am to 10:30am (GMT+1)
      New York : Tuesday, November 21st 2023 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Tuesday, November 21st 2023 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
      Istanbul : Tuesday, November 21st 2023 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Tuesday, November 21st 2023 from 09pm to 10:30pm (GMT+1)
      Bangkok : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
      Shanghai : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
      Tokyo : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
      Sydney : Wednesday, November 22nd 2023 from 03am to 04:30am (GMT+1)
      Wellington : Wednesday, November 22nd 2023 from 05am to 06:30am (GMT+1)

      Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

      Share
      Scroll Up